HealthCare Global Enterprises (NSE:HCG) Cyclically Adjusted PB Ratio: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
81 GF Score
Price ₹725.95
GF Value ₹604.01
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HealthCare Global Enterprises  (NSE:HCG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


HealthCare Global Enterprises Cyclically Adjusted PB Ratio Related Terms


HealthCare Global Enterprises Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Cyclically Adjusted PB Ratio Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 7.72 7.20

HealthCare Global Enterprises Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 8.93 0.00 7.20 0.00

NSE:HCG vs HCA, THC, DVA: Cyclically Adjusted PB Ratio Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthCare Global Enterprises Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's Cyclically Adjusted PB Ratio falls into.


NSE:HCG
81GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

HealthCare Global Enterprises's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, HealthCare Global Enterprises's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

HealthCare Global Enterprises Quarterly Data

Book Value per Share CPI Adj_Book
201609 52.946 105.961 83.624
201612 0.000 105.196 0.000
201703 50.168 105.196 79.813
201706 0.000 107.109 0.000
201709 49.852 109.021 76.527
201712 0.000 109.404 0.000
201803 58.908 109.786 89.799
201806 0.000 111.317 0.000
201809 54.429 115.142 79.112
201812 0.000 115.142 0.000
201903 53.882 118.202 76.289
201906 0.000 120.880 0.000
201909 51.279 123.175 69.673
201912 0.000 126.235 0.000
202003 42.723 124.705 57.335
202006 0.000 127.000 0.000
202009 64.857 130.118 83.419
202012 0.000 130.889 0.000
202103 55.273 131.771 70.200
202106 0.000 134.084 0.000
202109 62.704 135.847 77.248
202112 0.000 138.161 0.000
202203 62.221 138.822 75.011
202206 0.000 142.347 0.000
202209 62.958 144.661 72.836
202212 0.000 145.763 0.000
202303 61.476 146.865 70.054
202306 0.000 150.280 0.000
202309 61.219 151.492 67.630
202312 0.000 152.924 0.000
202403 58.921 153.035 64.436
202406 0.000 155.789 0.000
202409 61.448 157.882 65.136
202412 0.000 158.323 0.000
202503 65.759 157.552 69.852
202506 0.000 159.755 0.000
202509 64.891 162.289 66.917
202512 0.000 163.281 0.000
202603 89.213 164.272 90.888
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹725.95 is trading 20.2% above its estimated GF Value™ of ₹604.01. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹604.01 vs. price of ₹725.95 (20.2% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
81GF Score

Get the complete analysis for NSE:HCG

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹725.95
Price
₹604.01
GF Value